Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Cross

Showing results (31-40 of 180) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|March 10, 1979
Gamma-aminobutyric acid in the brain in schizophreniaA J Cross, T J Crow, F Owen
Neuroscience Letters|January 16, 1986
The association of [3H]D-aspartate binding and high-affinity glutamate uptake in the human brainA J Cross, W J Skan, P Slater
Neuroscience Letters|June 18, 1986
Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's diseaseA J Cross, P Slater, G P Reynolds
Psychopharmacology|January 1, 1981
3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptorsA J Cross, T J Crow, F Owen
British Journal of Pharmacology|May 1, 1979
The use of ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) as a ligand for brain dopamine receptors [proceedings]A J Cross, T J Crow, F Owen
British Journal of Pharmacology|May 1, 1979
The effect of neurotoxic lesions on neuronal systems in rat striatum [proceedings]A J Cross, F Owen, J L Waddington
Psychopharmacology|June 1, 1995
Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy")A R Green, A J Cross, G M Goodwin
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|September 1, 1995
The neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the ratS G Sydserff, A J Cross, A R Green
Annual Review of Pharmacology and Toxicology|August 31, 2016
CNS Target Identification and Validation: Avoiding the Valley of Death or Naive Optimism?P H Hutson, J A Clark, A J Cross
Biochemical Pharmacology|April 1, 1979
Distribution and inhibition characteristics of human brain monoamine oxidaseF Owen, A J Cross, R Lofthouse, et al.
Pageof 18

Showing results (31-40 of 180) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|March 10, 1979
Gamma-aminobutyric acid in the brain in schizophreniaA J Cross, T J Crow, F Owen
Neuroscience Letters|January 16, 1986
The association of [3H]D-aspartate binding and high-affinity glutamate uptake in the human brainA J Cross, W J Skan, P Slater
Neuroscience Letters|June 18, 1986
Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's diseaseA J Cross, P Slater, G P Reynolds
Psychopharmacology|January 1, 1981
3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptorsA J Cross, T J Crow, F Owen
British Journal of Pharmacology|May 1, 1979
The use of ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) as a ligand for brain dopamine receptors [proceedings]A J Cross, T J Crow, F Owen
British Journal of Pharmacology|May 1, 1979
The effect of neurotoxic lesions on neuronal systems in rat striatum [proceedings]A J Cross, F Owen, J L Waddington
Psychopharmacology|June 1, 1995
Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy")A R Green, A J Cross, G M Goodwin
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|September 1, 1995
The neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the ratS G Sydserff, A J Cross, A R Green
Annual Review of Pharmacology and Toxicology|August 31, 2016
CNS Target Identification and Validation: Avoiding the Valley of Death or Naive Optimism?P H Hutson, J A Clark, A J Cross
Biochemical Pharmacology|April 1, 1979
Distribution and inhibition characteristics of human brain monoamine oxidaseF Owen, A J Cross, R Lofthouse, et al.
Pageof 18